Professor Yang Shufang from Taizhou People’s Hospital Affiliated with Nanjing Medical University shared insights on the current management status of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Given that MASLD involves numerous risk factors including obesity, glycemic abnormalities, and metabolic disorders, its treatment requires multidisciplinary collaboration. Core therapeutic strategies focus on reducing body mass index (BMI) and […]
Tag: Metabolic dysfunction-associated steatotic liver disease
Pathogenesis and Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Professor Yang Shufang from Taizhou People’s Hospital Affiliated with Nanjing Medical University states that the liver serves as the core hub regulating energy, glucose, and lipid metabolism in the human body. Energy-dense diets combined with sedentary lifestyles readily trigger obesity, metabolic syndrome (MetS), and type 2 diabetes mellitus (T2DM)—key risk factors for MASLD development. The […]
MASLD Increases All-Cause Mortality Risk in Type 2 Diabetes
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly becoming one of the most prevalent chronic liver diseases worldwide. Although the disease directly impairs liver function, causing abnormal fat accumulation and hepatocellular injury, its most life-threatening threat often does not originate from liver lesions themselves. In fact, MASLD more commonly significantly elevates patients’ all-cause mortality risk […]